Document Detail


Evacuation of the cervix after methotrexate administration in the treatment of cervical pregnancy: five cases.
MedLine Citation:
PMID:  16740223     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Case studies of five consecutive patients with cervical pregnancy treated with a standard protocol are presented. The aim was to evaluate the place of evacuation with curettage followed or not by cervical tamponade as an additional modality in patients with cervical pregnancies treated initially with methotrexate (MTX). The five patients with cervical pregnancies were treated with local injection and systemic administration of MTX, while in four of them additional cervical evacuation was performed. In two patients, with a gestational age of more than 9 weeks, cervical tamponade was additionally applied. No complications occurred during evacuation with curettage after MTX, and two women managed to become pregnant spontaneously and progressed to full term.
Authors:
Grigoris Grimbizis; Kostantinos Chatzigeorgiou; Tryfon Tsalikis; Apostolos Athanasiadis; Theodoros Theodoridis; John N Bontis
Related Documents :
10423803 - Evaluation of the upper uterine cervix by the location of the vesicocervical fold of th...
14567813 - Laparoscopic transabdominal cervicoisthmic cerclage during pregnancy.
1128553 - Successful application of prenatal diagnosis in a pregnancy at risk for homozygous beta...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Reproductive biomedicine online     Volume:  12     ISSN:  1472-6483     ISO Abbreviation:  Reprod. Biomed. Online     Publication Date:  2006 Apr 
Date Detail:
Created Date:  2006-06-02     Completed Date:  2006-06-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101122473     Medline TA:  Reprod Biomed Online     Country:  England    
Other Details:
Languages:  eng     Pagination:  487-92     Citation Subset:  IM    
Affiliation:
1st Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Thessaloniki, Greece. grimbi@med.auth.gr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal / administration & dosage*
Adult
Cervix Uteri
Combined Modality Therapy
Female
Fertility
Humans
Methotrexate / administration & dosage*
Pregnancy
Pregnancy Trimester, First
Pregnancy, Ectopic / drug therapy*,  surgery*,  ultrasonography
Vacuum Curettage*
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cumulative pregnancy rates resulting from the use of fresh and frozen oocytes: 7 years' experience.
Next Document:  The importance of consistent FSH delivery in infertility treatment.